###begin article-title 0
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MutL</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain
###end article-title 0
###begin p 1
###xml 158 173 158 173 <email xmlns:xlink="http://www.w3.org/1999/xlink">gab@bittech.net</email>
To whom correspondence should be addressed at BitTech Inc., PO Box 1499, Agoura Hills, CA 91376-1499, USA. Tel: +1 805 495 7515; Fax: +1 805 495 1866; Email: gab@bittech.net
###end p 1
###begin p 2
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2</italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 535 559 535 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 792 799 792 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 932 939 932 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1019 1023 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1084 1091 1084 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1115 1119 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1677 1681 1677 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 2047 2051 2047 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 529 534 <span type="species:ncbi:4932">yeast</span>
###xml 535 559 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 608 613 <span type="species:ncbi:4932">yeast</span>
###xml 668 673 <span type="species:ncbi:4932">yeast</span>
###xml 728 733 <span type="species:ncbi:9606">human</span>
###xml 803 808 <span type="species:ncbi:4932">yeast</span>
###xml 844 849 <span type="species:ncbi:9606">human</span>
###xml 923 928 <span type="species:ncbi:4932">yeast</span>
###xml 966 971 <span type="species:ncbi:4932">yeast</span>
###xml 1146 1151 <span type="species:ncbi:4932">yeast</span>
###xml 1510 1515 <span type="species:ncbi:9606">human</span>
###xml 1671 1676 <span type="species:ncbi:9606">human</span>
Germline mutations in the DNA mismatch repair (MMR) genes MSH2 and MLH1 are responsible for the majority of hereditary non-polyposis colorectal cancer (HNPCC), an autosomal-dominant early-onset cancer syndrome. Genetic testing of both MSH2 and MLH1 from individuals suspected of HNPCC has revealed a considerable number of missense codons, which are difficult to classify as either pathogenic mutations or silent polymorphisms. To identify novel MLH1 missense codons that impair MMR activity, a prospective genetic screen in the yeast Saccharomyces cerevisiae was developed. The screen utilized hybrid human-yeast MLH1 genes that encode proteins having regions of the yeast ATPase domain replaced by homologous regions from the human protein. These hybrid MLH1 proteins are functional in MMR in vivo in yeast. Mutagenized MLH1 fragments of the human coding region were synthesized by error-prone PCR and cloned directly in yeast by in vivo gap repair. The resulting yeast colonies, which constitute a library of hybrid MLH1 gene variants, were initially screened by semi-quantitative in vivo MMR assays. The hybrid MLH1 genes were recovered from yeast clones that exhibited a MMR defect and sequenced to identify alterations in the mutagenized region. This investigation identified 117 missense codons that conferred a 2-fold or greater decreased efficiency of MMR in subsequent quantitative MMR assays. Notably, 10 of the identified missense codons were equivalent to codon changes previously observed in the human population and implicated in HNPCC. To investigate the effect of all possible codon alterations at single residues, a comprehensive mutational analysis of human MLH1 codons 43 (lysine-43) and 44 (serine-44) was performed. Several amino acid replacements at each residue were silent, but the majority of substitutions at lysine-43 (14/19) and serine-44 (18/19) reduced the efficiency of MMR. The assembled data identifies amino acid substitutions that disrupt MLH1 structure and/or function, and should assist the interpretation of MLH1 genetic tests.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c1">1</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c2">2</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c3">3</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c4">4</xref>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c7">7</xref>
###xml 992 993 992 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c8">8</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c10">10</xref>
###xml 1144 1146 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c11">11</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c12">12</xref>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 764 770 <span type="species:ncbi:9606">humans</span>
DNA mismatch repair (MMR) is a multi-protein intracellular process for recognizing and repairing non-native DNA structures. These incorrect structures arise primarily following DNA replication and during recombination [reviewed in (1,2)]. In the absence of normal MMR, the cellular mutation rate increases and this deficiency is evidenced by high levels of microsatellite instability (MSI), i.e. insertions and deletions in repetitive DNA sequences, and an accumulation of single nucleotide alterations. In agreement with the 'mutator hypothesis' (3), which predicts an association between the increased mutation rates and tumorigenesis, mice that carry MMR gene deficiencies display elevated levels of MSI and have an increased susceptibility to cancer (4-7). In humans, heterozygosity for mutations in MMR genes results in predisposition to hereditary non-polyposis colorectal cancer (HNPCC), an autosomal-dominant syndrome characterized by early-onset colorectal cancer and other cancers (8-10). Depending on the population and clinical criteria used, recent studies suggest that HNPCC may comprise 2-8% of all colorectal cancers worldwide (11,12).
###end p 4
###begin p 5
###xml 104 120 104 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 132 156 132 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c13">13</xref>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c1">1</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c2">2</xref>
###xml 1327 1329 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c14">14</xref>
###xml 1330 1332 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c15">15</xref>
###xml 1465 1467 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c16">16</xref>
###xml 1468 1470 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c17">17</xref>
###xml 1500 1502 1476 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c18">18</xref>
###xml 1503 1505 1479 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c19">19</xref>
###xml 1590 1592 1562 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c20">20</xref>
###xml 1593 1595 1565 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c22">22</xref>
###xml 1728 1730 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c23">23</xref>
###xml 1731 1733 1703 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c24">24</xref>
###xml 1759 1761 1731 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c25">25</xref>
###xml 1762 1764 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c26">26</xref>
###xml 1810 1812 1782 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c27">27</xref>
###xml 1813 1815 1785 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c28">28</xref>
###xml 1875 1877 1847 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c29">29</xref>
###xml 1878 1880 1850 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c33">33</xref>
###xml 104 120 <span type="species:ncbi:562">Escherichia coli</span>
###xml 126 131 <span type="species:ncbi:4932">yeast</span>
###xml 132 156 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 161 167 <span type="species:ncbi:9606">humans</span>
###xml 172 178 <span type="species:ncbi:562">E.coli</span>
###xml 603 608 <span type="species:ncbi:4932">yeast</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
###xml 663 669 <span type="species:ncbi:562">E.coli</span>
###xml 999 1005 <span type="species:ncbi:9606">humans</span>
###xml 1160 1166 <span type="species:ncbi:9606">humans</span>
The basic mechanisms and protein components of MMR are conserved in a broad range of species, including Escherichia coli, the yeast Saccharomyces cerevisiae and humans. In E.coli, a protein complex composed of two MutS proteins recognizes and binds to single nucleotide mispairs and insertion-deletion loops in post-replicative DNA. Homodimers composed of two MutL proteins subsequently interact with the MutS:DNA complex and coordinate subsequent repair events involving the endonuclease MutH and several other proteins that excise the non-native DNA strand and synthesize a corrected version (13). In yeast and human cells, there exist multiple homologs of the E.coli MutS and MutL proteins and these interact in several combinations to effect MMR (1,2). The MutS homologs (MSH2, MSH3 and MSH6) form the heterodimers MSH2-MSH6 (MutSalpha) and MSH2-MSH3 (MutSbeta), which bind to mispaired DNA in an 'error-specific' manner. Heterodimers composed of the MutL homologs [MLH1, MLH3 and PMS1 (PMS2 in humans)] then interact with the MSH2-containing complexes and coordinate downstream repair events. The heterodimer MutLalpha, composed of MLH1 and PMS1 (PMS2 in humans), interacts with both MutSalpha and MutSbeta, while the heterodimer MutLbeta, composed of MLH1 and MLH3, appears restricted to interactions with only MutSbeta (14,15). The MLH1-containing heterodimers are essential for signaling downstream MMR events, which appear to involve the exonuclease EXO1 (16,17), DNA replication protein A (18,19) and proliferating cell nuclear antigen/POL30, a component of DNA polymerase delta (20-22). In addition, certain MMR proteins have been implicated in cellular functions apart from MMR. These include mitotic recombination (23,24), meiotic crossing over (25,26), immunoglobulin class-switch recombination (27,28) and the induction of apoptosis in response to DNA damage (29-33).
###end p 5
###begin p 6
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c34">34</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c36">36</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c40">40</xref>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c38">38</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c40">40</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c43">43</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c44">44</xref>
###xml 914 916 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 917 919 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c44">44</xref>
###xml 920 922 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c46">46</xref>
###xml 54 59 <span type="species:ncbi:4932">yeast</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 262 268 <span type="species:ncbi:562">E.coli</span>
###xml 434 440 <span type="species:ncbi:562">E.coli</span>
###xml 657 663 <span type="species:ncbi:9606">humans</span>
The MLH1 protein (MLH1p) is essential for MMR in both yeast and human cells (34-36). Structure-function studies of MLH1p have revealed the importance of an ATPase domain in the N-terminal region (37-40). Crystal structures of the conserved N-terminal portion of E.coli MutL has provided insights into the workings of the ATPase domain, which is highly conserved in the GHL (gyrase b/hsp90/mutL) family of ATPases (41,42). As with the E.coli MutL protein, binding and hydrolysis of ATP triggers a conformational change in MLH1p which appears to mediate downstream MMR events (38-40). These events appear to be dependent on binding of yMLH1 to yPMS1 (PMS2 in humans) through a domain in the C-terminal end of MLH1p (43,44). Interestingly, recent studies have shown the importance of additional amino acid residues in the N-terminal end for proper yMLH1-yPMS1 interaction and hMutLalpha-hMutSalpha complex formation (37,44-46). Taken together, it appears that the N-terminal end of MLH1p may have multiple functions in the process of MMR.
###end p 6
###begin p 7
###xml 180 184 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 189 193 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2</italic>
###xml 201 202 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c8">8</xref>
###xml 203 205 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c10">10</xref>
###xml 239 243 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 248 252 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2</italic>
###xml 613 617 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 624 626 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c47">47</xref>
###xml 674 676 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c43">43</xref>
###xml 677 679 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c45">45</xref>
###xml 776 783 764 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 908 912 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 917 921 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MSH2</italic>
###xml 939 941 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c43">43</xref>
###xml 942 944 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c48">48</xref>
###xml 945 947 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c50">50</xref>
###xml 1316 1318 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 1359 1363 1347 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1526 1530 1514 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1546 1548 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 534 539 <span type="species:ncbi:9606">human</span>
###xml 562 567 <span type="species:ncbi:4932">yeast</span>
###xml 607 612 <span type="species:ncbi:9606">human</span>
###xml 801 806 <span type="species:ncbi:4932">yeast</span>
###xml 849 854 <span type="species:ncbi:9606">human</span>
###xml 1002 1007 <span type="species:ncbi:9606">human</span>
###xml 1347 1352 <span type="species:ncbi:9606">human</span>
###xml 1353 1358 <span type="species:ncbi:4932">yeast</span>
###xml 1423 1428 <span type="species:ncbi:4932">yeast</span>
###xml 1469 1474 <span type="species:ncbi:9606">human</span>
###xml 1520 1525 <span type="species:ncbi:9606">human</span>
Germline genetic testing of individuals suspected of HNPCC has revealed over 300 different alterations in MMR genes with the vast majority (approximately90%) of these being in the MLH1 and MSH2 genes (8,10). Approximately one-third of the MLH1 and MSH2 alterations are missense codons whose functional consequence is not immediately obvious. These 'variants of uncertain significance' require further investigation to determine whether each may be a pathogenic mutation or a silent polymorphism. In some cases, the consequence of the human alteration was tested yeast using a dominant mutator effect of the human MLH1 gene (47) or the loss of binding to other MMR proteins (43-45). However, these investigations do not assay the biological activity of the protein. The use of in vivo MMR assays using yeast genes with an alteration identical to the human alteration has allowed a functional analysis of many MLH1 and MSH2 missense codons (43,48-50). In a recent investigation of 18 previously observed human alterations, it was shown that missense codons may lead to expression of a MMR protein with no reduction in the MMR efficiency ('silent polymorphisms'), complete elimination of MMR function ('inactivating mutations') or a protein that functions in MMR with a reduced efficiency ('efficiency polymorphisms') (51). The development of hybrid human-yeast MLH1 genes, which encode proteins that are functional in MMR in yeast cells, has made possible an analysis of human missense codons in the context of the native human MLH1 gene sequence (51).
###end p 7
###begin p 8
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 371 378 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 546 553 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 950 957 950 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 220 225 <span type="species:ncbi:9606">human</span>
###xml 226 231 <span type="species:ncbi:4932">yeast</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:4932">yeast</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
###xml 870 875 <span type="species:ncbi:9606">human</span>
The aim of the current investigation is to identify novel MLH1 missense codons that impair MMR function. To obtain functional information relevant to the native human MLH1 gene, a prospective genetic screen using hybrid human-yeast genes was developed. The human coding sequence of hybrid MLH1 genes was mutagenized by error-prone PCR, and these fragments were cloned by in vivo gap repair transformation in yeast to generate a library of clones containing a high frequency of mutations in the human coding sequence. The clones were subjected to in vivo MMR assays to identify transformants with a MMR deficiency. Sequence analysis of these mutant MLH1 genes led to the identification of 117 unique single missense codons that eliminated or reduced the efficiency of MMR compared to the parental hybrid molecule. In addition, all 19 possible amino acid substitutions at human MLH1p residues 43 (lysine-43) and 44 (serine-44) were tested for function in vivo. The majority of substitutions at lysine-43 (14/19) and serine-44 (18/19) impaired MMR function. Collectively, the results provide information that may assist in the interpretation of HNPCC genetic tests when 'variants of uncertain significance' are observed.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast expression vectors
###end title 10
###begin p 11
###xml 27 29 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c52">52</xref>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MET25</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYC1</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MET25</italic>
###xml 399 411 399 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 708 712 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRP1</italic>
###xml 869 873 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 918 920 918 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">16</sub>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c53">53</xref>
###xml 211 217 <span type="species:ncbi:562">E.coli</span>
###xml 399 411 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 601 606 <span type="species:ncbi:9606">human</span>
###xml 702 707 <span type="species:ncbi:4932">yeast</span>
Plasmid pMETc [p413MET25, (52)] contains a HIS3 selectable marker, a centromere sequence (CEN6) for mitotic stability, an ARS4 origin of DNA replication, the ampicillin-resistance gene for positive selection in E.coli and a multicloning site between the MET25 promoter and CYC1 terminator. Plasmid pMLH1, a derivative of pMETc lacking the MET25 promoter, contains a 3.8 kb genomic DNA fragment from S.cerevisiae strain S288C including the MLH1 gene coding sequence and 1.5 kb of 5' flanking sequence (51). Plasmids pMLH1_h(41-86) and pMLH1_h(77-134) are identical to pMLH1 but contain codons encoding human MLH1p amino acid residues 41-86 and 77-134, respectively, in place of the homologous codons of yeast MLH1 (51). Plasmid pSH91 contains a TRP1 selectable marker, a centromere sequence (CEN11), an ARS1 origin of replication, the ampicillin-resistance gene and the URA3 coding sequence preceded by an in-frame (GT)16G tract (53).
###end p 11
###begin title 12
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains, growth conditions and transformations
###end title 12
###begin p 13
###xml 49 61 49 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 70 143 70 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT&#945; ade2-101 his3-&#916;200 leu2-&#916;1 lys2-801 trp1-&#916;63 ura3-52</italic>
###xml 146 148 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c54">54</xref>
###xml 244 333 228 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT&#945; ade2-101 his3-&#916;200 leu2-&#916;1 lys2-801 trp1-&#916;63 ura3-52 mlh1&#916;::LEU2</italic>
###xml 335 337 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 401 497 365 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT&#945; ADE2::MS3::ADE2 his3-&#916;200 leu2-&#916;1 lys2-801 trp1-&#916;63 ura3-52 mlh1&#916;::LEU2</italic>
###xml 504 507 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MS3</italic>
###xml 581 583 525 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">19</sub>
###xml 587 589 531 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18</sub>
###xml 648 652 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 677 678 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f1">1</xref>
###xml 731 735 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 820 832 764 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 994 998 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 1088 1100 1032 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 1442 1444 1386 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c55">55</xref>
###xml 1776 1780 1711 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 1814 1829 1749 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 1883 1887 1818 1822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 2434 2436 2369 2371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c56">56</xref>
###xml 49 61 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 725 730 <span type="species:ncbi:4932">yeast</span>
###xml 820 832 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 1088 1100 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 1728 1733 <span type="species:ncbi:4932">yeast</span>
The strains used in this study were derived from S.cerevisiae YPH500 (MATalpha ade2-101 his3-Delta200 leu2-Delta1 lys2-801 trp1-Delta63 ura3-52) (54). The strain YBT24 contains a deletion of the entire MLH1 coding sequence and has the genotype MATalpha ade2-101 his3-Delta200 leu2-Delta1 lys2-801 trp1-Delta63 ura3-52 mlh1Delta::LEU2 (51). The strain YBT41 was derived from YBT24 and has the genotype MATalpha ADE2::MS3::ADE2 his3-Delta200 leu2-Delta1 lys2-801 trp1-Delta63 ura3-52 mlh1Delta::LEU2 where MS3 refers to a cloned synthetic oligonucleotide introducing an in-frame (AC)19A(G)18 microsatellite between the first and second codons of the ADE2 coding sequence (Figure 1A). The strain was constructed as follows: the yeast ADE2 translation initiation codon and 644 bp 5' flanking sequence was PCR amplified from S.cerevisiae S288C DNA using the primers d(CGC GAT CGA TCA TGC TTA TGG GTT AGC) (H374-4) and d(GTG TGT GTG TGT GTG TGT GTG TGT GTC ATA CTT GAT TGT TTT GTC CG) [1-51-10]. The ADE2 coding sequence from codon 2 to 36 bp 3' to the termination codon was PCR amplified from S.cerevisiae S288C DNA using the primers d(ACA CAC ACA CAC ACA CAC ACA CAC ACA CAC ACA CAC ACA GGG GGG GGG GGG GGG GGG GAT TCT AGA ACA GTT GGT ATA TTA G) [1-51-9] and d(TTA TTT GCT GTA CAA GTA TAT CAA TAA AC) [1-51-13]. The 673 and 1808 bp DNA fragments were mixed in approximately equimolar amounts and subjected to overlap extension PCR amplification (55) using primers H374-4 and 1-51-13. The predominant amplification product was the 2452 bp overlap extension PCR product. The DNA was purified (Wizardtrade mark PCR Preps DNA Purification kit, Promega) and transformed into YBT24 containing pSH91 selecting for adenine prototrophs. The yeast strain YBT41 was shown to have the native ADE2 chromosomal gene replaced by the ADE2::MS3::ADE2 allele by PCR amplification of chromosomal DNA using ADE2-specific and microsatellite-specific primers (data not shown). The strain YBT24 containing pSH91 was grown in synthetic dextrose (SD) medium supplemented with adenine, histidine and lysine. The strain YBT41 containing pSH91 was grown in SD medium supplemented with histidine and lysine. The strains YBT24 and YBT41 containing pSH91 were transformed with pMLH1-derived expression vectors or the parental vector pMETc and histidine prototrophs were selected. All transformations were performed using the polyethylene glycol-lithium acetate method (56).
###end p 13
###begin title 14
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Error-prone PCR and in vivo gap repair cloning
###end title 14
###begin p 15
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 161 164 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 238 240 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c57">57</xref>
###xml 801 805 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1267 1268 1228 1229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1320 1323 1281 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 1427 1434 1379 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1464 1466 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c58">58</xref>
###xml 1467 1469 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c60">60</xref>
###xml 1536 1546 1486 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ClaI&#8211;AatII</italic>
###xml 1785 1789 1735 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 772 777 <span type="species:ncbi:9606">human</span>
###xml 1457 1462 <span type="species:ncbi:4932">yeast</span>
###xml 1646 1651 <span type="species:ncbi:4932">Yeast</span>
Pools of mutant MLH1 gene fragments were generated by error-prone PCR using Mutazymetrade mark (a component of the GeneMorph PCR mutagenesis kit, Stratagene) or Taq (Promega) DNA polymerases, which have different misincorporation biases (57). The use of both enzymes should ensure that pools of mutagenized DNA are representative of all possible base substitutions. The XhoI-linearized plasmids pMLH1_h (41-86) and pMLH1_h(77-134) were used as templates in PCR mixes containing the buffers, nucleotides and enzyme concentrations recommended by the manufacturer of each DNA polymerase. The upstream and downstream primers were d(GCT GCA GGT GAG ATC ATA ATA TCC) (E124-1) and d(TCA ACT AGG ATC GTG GTA C) (D545-9), respectively, which amplify a 401 bp fragment spanning the human portion of each hybrid MLH1 gene. In preliminary experiments, the upstream primer d(GCG CGG ATC CAT AGA CCT ATC AAT AAG C) (R472-1) was used to generate a fragment of 475 bp. The protocol for temperature cycling was: 94degreesC for 2 min, 33 cycles of 94degreesC for 36 s, 55degreesC for 1 min, 72degreesC for 2 min and 72degreesC for 10 min. Conditions of high and low fidelity were manipulated by varying the amount of template DNA (3-74 ng) in reactions containing Mutazyme and the MgCl2 concentration (1.5-2.5 mM) in reactions containing Taq DNA polymerase. The PCR fragments were purified with Wizardtrade mark PCR Preps (Promega) and used for in vivo gap repair cloning in yeast (58-60). Briefly, 0.5 mug purified PCR product was combined with 0.4 mug ClaI-AatII digested pMLH1 vector and the DNA mixture was co-transformed into YBT24 or YBT41 containing pSH91. Yeast cells in which fragment and vector recombine were stable transformants converted to histidine prototrophs due to the presence of the HIS3 marker gene on the pMLH1 expression vector. This process typically yielded approximately500 transformants (i.e. colonies) per plate; while equivalent transformations performed with restricted vector alone exhibited very few (<5) colonies per plate.
###end p 15
###begin title 16
Identification of MMR-deficient transformants
###end title 16
###begin title 17
Method 'a':
###end title 17
###begin p 18
###xml 604 608 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura3</italic>
###xml 655 657 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">16</sub>
###xml 681 685 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura3</italic>
###xml 729 731 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c48">48</xref>
###xml 732 734 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c53">53</xref>
###xml 1585 1589 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAN1</italic>
###xml 290 295 <span type="species:ncbi:4932">yeast</span>
###xml 1877 1882 <span type="species:ncbi:4932">Yeast</span>
When gap repair cloning was carried out in YBT24 containing pSH91, transformants were assayed sequentially using a spot test for 5-fluoroorotic acid (FOA) resistance and a patch test for canavanine resistance. Briefly, individual clones from the transformation were grown in 3 ml SD (0.67% yeast nitrogen base without amino acids, 2% dextrose) medium containing adenine and lysine (day 1 culture), and the next day 120 mul of the saturated culture was subinoculated into 3 ml fresh SD medium containing adenine, lysine and uracil. The addition of uracil in the medium allows growth of cells containing a ura3 mutation arising from a frameshift in the (GT)16G-tract of pSH91. These ura3 mutants exhibit a FOA-resistant phenotype (48,53). Following 24 h growth, 4 mul of the culture was spotted in duplicate on SD plates containing adenine, lysine, uracil and 1 mg/ml FOA (Toronto Research Chemicals Inc., ON, Canada). The plates were incubated at 30degreesC for 48 h and then scored by counting the number of FOA-resistant colonies on each spot. Transformants that exhibited few colonies (<15, typically 0-5) per spot were scored as having low levels of MSI (i.e. MMR proficient) and were not analyzed further. Transformants that exhibited many colonies (>/=15, typically 20-50) per spot were scored as having high levels of MSI (i.e. MMR deficient) and were arrayed on a master plate by applying 25 mul the day 1 cultures to SD plates containing adenine and lysine. These clones were subjected to a secondary assay based on spontaneous forward mutations in the arginine permease gene (CAN1), which cause resistance to canavanine. A 1 mul loop of cells from the arrayed transformants were patched out on SD plates containing adenine, lysine and 60 mug/ml canavanine. Plates were incubated 3 days at 30degreesC and scored by counting the number of canavanine-resistant colonies. Yeast clones that exhibited few colonies (<15) were scored as having low levels of genetic instability (i.e. normal in MMR) and were not analyzed further. Clones that exhibited many colonies (>/=15, typically 30-100) were selected for further analysis.
###end p 18
###begin title 19
Method 'b':
###end title 19
###begin p 20
###xml 5 12 5 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 211 213 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c60">60</xref>
###xml 250 254 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 381 385 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 421 436 420 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 473 477 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade2</italic>
When in vivo gap repair was carried out in YBT41, the transformed cells were plated directly on SD plates containing low concentrations (4 mug/ml) of adenine and incubated for 4-5 days. As described previously (60), the cells that do not express the ADE2 gene form red colonies due to the accumulation of an intermediate in adenine biosynthesis, while cells expressing a wild-type ADE2 gene form white colonies. When the ADE2::MS3::ADE2 allele is unstable (i.e. mutates to ade2- at a high frequency due to instability of the MS3 microsatellite), the strain forms a white colony with red sectors on plates containing low adenine (see Results). In Method 'b', after gap repair transformation and growth on plates containing 4 mug/ml adenine, colonies that exhibit abundant red-white sectoring were selected for further analysis.
###end p 20
###begin title 21
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 15 20 <span type="species:ncbi:4932">yeast</span>
Preparation of yeast DNA and isolation of mutant MLH1 expression vectors
###end title 21
###begin p 22
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c61">61</xref>
###xml 116 117 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 287 291 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 329 335 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 6 11 <span type="species:ncbi:4932">yeast</span>
###xml 156 161 <span type="species:ncbi:4932">yeast</span>
###xml 329 335 <span type="species:ncbi:562">E.coli</span>
Total yeast DNA was prepared from 15 ml liquid cultures using the glass-bead method (61) and resuspended in 50 mul H2O. To recover mutant plasmids from the yeast strain, a 15 mul aliquot of each DNA sample was digested with BamHI, which restricts the pSH91 expression vector but not the MLH1 expression vector, and shuttled into E.coli strain DH5alpha by electroporation using a BTX ECM399 system (Genetronics, Inc.). Bacterial colonies were selected by growth on Luria-Bertani plates containing 50 mug/ml ampicillin and plasmid DNA was purified using the Wizard Plus SV Minipreps kit (Promega).
###end p 22
###begin title 23
###xml 15 20 <span type="species:ncbi:9606">human</span>
Mutagenesis of human MLH1 codons 43 and 44
###end title 23
###begin p 24
###xml 355 359 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 469 472 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu</italic>
###xml 764 767 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 773 776 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aat</italic>
###xml 796 799 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 801 804 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aat</italic>
###xml 885 889 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 916 922 874 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1943 1946 1897 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 1948 1951 1902 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aat</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:4932">yeast</span>
###xml 916 922 <span type="species:ncbi:562">E.coli</span>
###xml 1716 1721 <span type="species:ncbi:9606">human</span>
For mutagenesis of human codon 43 (lysine-43), a degenerate primer with the sequence d(CTG TAT CGA TGC ANN NTC CAC AAG TAT TCA AGT G) (E124-1.7), where 'N' represents any of the four nucleotides A, C, G or T, was used in combination with primer d(CAG TTT AGA CGT CGT GAA CCT TTC ACA TAC) (E466-1) to PCR amplify an approximately140 bp fragment from human MLH1 cDNA clone (accession no. 217884) (American Type Culture Collection). Amplification of the fragment utilized Pfu DNA polymerase (Stratagene) and the recommended buffers and nucleotide concentrations. Cycling conditions were as follows: 95degreesC for 2 min; 33 cycles of 95degreesC for 36 s, 55degreesC for 1 min, 72degreesC for 2 min, and 72degreesC for 10 min. The resulting fragment was digested with ClaI and AatII and ligated into ClaI-AatII digested pMLH1 vector replacing the corresponding portion of the native yeast MLH1 gene. Transformation into E.coli strain DH5alpha yielded ampicillin-resistant colonies that contained plasmids identical to pMLH1_h(41-86) except for the mutant codon at position 43. Plasmid DNA was purified from individual colonies and prepared for DNA sequencing to determine the identity of codon 43 and also verify the sequence of the cloned PCR fragment. Plasmids containing codons for 13 of the 20 possible amino acid substitutions were identified in this way. Plasmids containing codons for the seven remaining amino acid substitutions were generated by direct cloning of PCR products. These variants were generated using primers identical to E124-1.7 except for the following triplets at codon 43: 'TGT' (K43C), 'GAA' (K43E), 'CAT' (K43H), 'AAG' (K43K), 'CCT' (K43P), 'CAA' (K43Q) and 'TGG' (K43W). For mutagenesis of human codon 44 (serine-44), a degenerate primer with the sequence d(CTG TAT CGA TGC AAA ANN NAC AAG TAT TCA AGT G) (E124-8) was used in combination with primer E466-1 to amplify a 122 bp portion of the hMLH1 gene. Cloning into ClaI-AatII digested pMLH1 vector was the same as described above for mutagenesis of codon 43. Plasmids identical to pMLH1_h(41-86), but containing codons for 14 of the 20 possible amino acid substitutions at codon 44, were identified in this way. In addition, a hybrid gene containing the stop codon 'TGA' at codon 44 was identified. Plasmids containing codons for the remaining six amino acid substitutions were generated by direct cloning using primers identical to E124-8 except for the following triplet at codon 43: 'GAC' (S44D), 'GAG' (S44E), 'GGC' (S44G), 'AAG' (S44K), 'ATG' (S44M) and 'AAC' (S44N).
###end p 24
###begin title 25
DNA sequencing
###end title 25
###begin p 26
DNA sequencing was performed at commercial facilities using dye-terminator chemistry and automated sequencers (ABI models 377 and 3700, Applied Biosystems). Chromatogram and text files were analyzed with Chromas (version 1.45, ) and GeneRunner (version 3.04, Hastings Software Inc.) software, respectively. Sequencing was carried out in both the forward and reverse directions using primers d(GGA GTT CTC GAA GAC GAG) (D806-1), D545-9 and/or d(CGG GTG AAC GTT AAC ATC) (D545-10).
###end p 26
###begin title 27
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Quantitative in vivo MMR assays
###end title 27
###begin p 28
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura3</italic>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c48">48</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura3</italic>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">16</sub>
###xml 442 445 442 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">595</sub>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 705 708 705 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink">595</sub>
###xml 749 752 749 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">595</sub>
###xml 763 764 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c62">62</xref>
###xml 1105 1109 1105 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1239 1242 1239 1242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">595</sub>
Standardized MMR assays based on mutation to ura3 FOAr were performed as described previously (48,51). Briefly, YBT24 transformants containing an MLH1 expression vector and pSH91 were cultured overnight in medium lacking uracil and subcultured in liquid media containing adenine, lysine and uracil, which allows growth of ura3 FOAr mutants [which arise as a result of slippage in the (GT)16G-tract]. After 24 h in culture, optical density (OD595) measurements were taken and an aliquot was plated on SD plates containing adenine, lysine, uracil and 1 mg/ml FOA. Mutation frequencies were calculated as described previously (51), except that the concentration (CFU/ml) of total cells was determined from OD595 readings using the determined value 1 OD595 = 1.1 x 107 CFU/ml. The MMR defect is defined as the ratio of the mutation frequency in the test strain divided by that observed in the appropriate MMR-proficient control strain. Forward mutation rates to canavanine resistance were determined by fluctuation analysis using the method of the median (62). Individual colonies (YBT24 transformed with the MLH1 expression vector of interest) were expanded in liquid SD media containing the appropriate supplements. After 24 h in culture, OD595 measurements were taken and an aliquot was plated on SD plates containing the appropriate supplements and 60 mug/ml canavanine. Canavanine-resistant colonies were counted after 2-3 days growth at 30degreesC. Mutation frequencies were determined by dividing the concentration (CFU/ml) of canavanine-resistant colonies by the concentration (CFU/ml) of total cells. The MMR defect is defined as the ratio of the mutation frequency in the test strain divided by that observed in the same strain complemented by the appropriate control gene.
###end p 28
###begin title 29
MLH1p accession numbers, alignment and mutation databases
###end title 29
###begin p 30
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 25 37 25 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 47 64 47 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus</italic>
###xml 77 100 77 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 113 137 113 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 150 175 150 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 188 208 188 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana</italic>
###xml 221 243 221 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 256 272 256 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 288 309 288 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c63">63</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c66">66</xref>
###xml 0 12 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 25 37 <span type="species:ncbi:10090">Mus musculus</span>
###xml 47 64 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 77 100 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 113 137 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 150 175 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 188 208 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 221 243 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 256 272 <span type="species:ncbi:562">Escherichia coli</span>
###xml 288 309 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 461 466 <span type="species:ncbi:9606">human</span>
###xml 615 620 <span type="species:ncbi:9606">Human</span>
Homo sapiens, NP_000240; Mus musculus, Q9JK91; Rattus norvegicus, NP_112315; Drosophila melanogaster, NP_477022; Saccharomyces cerevisiae, NP_013890; Schizosaccharomyces pombe, NP_596199; Arabidopsis thaliana, NP_567345; Caenorhabditis elegans, NP_499796; Escherichia coli, NP_418591 and Staphylococcus aureus, Q93T05. Sequences were retrieved from the Protein Database of the National Center for Biotechnology Information () and aligned using ClustalW (). The human MLH1 alterations were reported in the literature (63-66) or the following public mutation databases: International Collaborative Group on HNPCC (), Human Gene Mutation Database () and Swiss-protein (). The databases were last examined in May 2004.
###end p 30
###begin title 31
RESULTS
###end title 31
###begin title 32
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 36 41 <span type="species:ncbi:4932">yeast</span>
Functional analysis of hybrid human-yeast MLH1 genes
###end title 32
###begin p 33
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 353 360 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 438 440 438 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink">16</sub>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c48">48</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c53">53</xref>
###xml 597 604 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlh1</italic>
###xml 781 797 781 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3:: ADE2</italic>
###xml 813 814 813 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f1">1</xref>
###xml 840 844 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1112 1113 1111 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f2">2</xref>
###xml 1124 1125 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 1132 1147 1131 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 1408 1409 1407 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 1496 1498 1495 1497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">19</sub>
###xml 1502 1504 1501 1503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18</sub>
###xml 1561 1565 1560 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 1672 1673 1671 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 1697 1712 1696 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 2001 2002 1988 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 2135 2150 2122 2137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 2352 2356 2339 2343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAN1</italic>
###xml 2364 2366 2351 2353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c67">67</xref>
###xml 2373 2377 2360 2364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 2425 2429 2412 2416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 2664 2668 2651 2655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAN1</italic>
###xml 2699 2701 2686 2688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 2748 2752 2735 2739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 2808 2810 2795 2797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 2818 2819 2805 2806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 2992 2994 2979 2981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 3007 3009 2994 2996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 3426 3430 3413 3417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 3696 3698 3683 3685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 3707 3708 3694 3695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 10 15 <span type="species:ncbi:4932">yeast</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:4932">yeast</span>
###xml 238 243 <span type="species:ncbi:4932">yeast</span>
###xml 705 710 <span type="species:ncbi:4932">yeast</span>
###xml 2742 2747 <span type="species:ncbi:4932">yeast</span>
###xml 2866 2871 <span type="species:ncbi:4932">yeast</span>
###xml 2921 2926 <span type="species:ncbi:4932">yeast</span>
###xml 3307 3312 <span type="species:ncbi:9606">human</span>
###xml 3313 3318 <span type="species:ncbi:4932">yeast</span>
###xml 3420 3425 <span type="species:ncbi:4932">yeast</span>
###xml 3545 3550 <span type="species:ncbi:4932">yeast</span>
The human-yeast hybrid genes MLH1_h(41-86) and MLH1_h(77-134) encode chimeric MLH1 proteins that contain 46 and 58 amino acid regions, respectively, of human MLH1p replacing the homologous region of yeast MLH1p. When expressed in haploid yeast cells containing a deletion of the chromosomal MLH1 gene, these hybrids were active in MMR in a standardized in vivo assay that measures the frequency of frameshift mutations in an in-frame (GT)16G microsatellite preceding the URA3 gene (48,51,53). In the present study, the function of MLH1_h(41-86) and MLH1_h(77-134) was confirmed and extended using in vivo MMR assays that employ two other reporter genes. The first assay involved transformation of haploid yeast strain YBT41, which contains a chromosomal mlh1-null deletion and the ADE2::MS3:: ADE2 allele (Figure 1A) in place of the native ADE2 allele on chromosome XV. The strain YBT41 was transformed with pMLH1, pMLH1_h(41-86), pMLH1_h(77-134) or pMETc (the expression vector lacking an MLH1 gene), and histidine prototrophs were selected on plates containing low concentrations (4 mug/ml) of adenine (Figure 2 and Table 1). The ADE2::MS3::ADE2 allele allowed a determination of MMR proficiency based on the presence or absence of red-white sectoring in individual colonies. When strain YBT41 was transformed with pMETc, and thus did not express MLH1p, >95% of the colonies were red-white sectored (Table 1, 'None'). This sectoring is likely due to the extreme instability of the in-frame (AC)19A(G)18 microsatellite resulting in frameshift mutations in the ADE2 gene. In contrast, when strain YBT41 was transformed with pMLH1, <2% of the colonies were sectored (Table 1). The integrity of the ADE2::MS3::ADE2 allele is maintained by the MMR process such that >98% of the colonies appeared white. When strain YBT41 was transformed with hybrids MLH1_h(41-86) and MLH1_h(77-134), the percentage of colonies exhibiting a red-white sectored appearance was approximately14% and <2%, respectively (Table 1). These results indicate that MLH1_h(41-86) and pMLH1_h(77-134) encode MLH1 proteins that efficiently maintain the stability of the ADE2::MS3::ADE2 allele. The second MMR assay was based on forward mutation to canavanine resistance, which detects mainly base substitutions and frameshift mutations in mononucleotide tracts in the arginine permease (CAN1) gene (67). The MLH1-deletion strain YBT24 was transformed with the MLH1 expression vectors, nine individual transformants were grown overnight in liquid culture and an aliquot was plated on solid growth media containing canavanine. The strain YBT24 containing the empty expression vector pMETc exhibited a CAN1 mutation frequency of 3.1 x 10-4, while the strain expressing the native yeast MLH1 gene (pMLH1) exhibited a mutation frequency of 7.1 x 10-6 (Table 1). This represents a mutation defect of 44 for yeast cells lacking MLH1p. The mutation frequencies of yeast cells expressing pMLH1_h(41-86) and pMLH1_h(77-134) were 2.8 x 10-5 and 1.7 x 10-5, respectively, which corresponded to mutation defects of 4.0 and 2.4. These results demonstrate that MLH1 proteins encoded by MLH1_h(41-86) and MLH1_h(77-134) are functional in the repair of a variety of DNA mismatch structures. Although the mutation frequencies exhibited by cells expressing the human-yeast hybrid genes are slightly elevated compared to those levels exhibited by cells expressing the native yeast MLH1 gene, the mutation frequencies conferred by the hybrids are at least 10-fold lower than those levels exhibited by yeast cells lacking any functional MLH1p. The complementation efficiencies for MLH1_h(41-86) and MLH1_h(77-134) are consistent with previous studies [(51); Table 1], and show that MLH1_h(77-134) is more proficient than MLH1_h(41-86) in MMR.
###end p 33
###begin title 34
Prospective screen for mutations in the MLH1 ATPase domain
###end title 34
###begin p 35
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f1">1</xref>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f1">1</xref>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura3</italic>
###xml 968 982 968 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS::ADE2</italic>
###xml 995 1002 995 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 160 165 <span type="species:ncbi:4932">yeast</span>
###xml 216 221 <span type="species:ncbi:4932">yeast</span>
To generate random mutations in MLH1, 5' end fragments of the MLH1_h(41-86) and MLH1_h(77-134) genes were synthesized by error-prone PCR and cloned directly in yeast by in vivo gap repair (Figure 1B). About 300-1000 yeast colonies, each representing a cloned PCR fragment, were obtained under the conditions utilized. As shown in Figure 1B, two methods were employed to identify colonies having a deficiency in MMR. In initial experiments, strain YBT24 containing pSH91 was used for in vivo gap repair (see Materials and Methods, Method 'a'), and transformants were screened for resistance to FOA (ura3) by a semi-quantitative spot test. Those that exhibited a high number of FOA-resistant colonies compared to transformants containing unmutagenized hybrid plasmid were then subjected to canavanine patch analysis, and transformants scored as mutants in both screens subjected to further analysis. The second screening method utilized strain YBT41, which contains the ADE2::MS::ADE2 allele, for in vivo gap repair (see Materials and Methods, Method 'b'). This method allowed single-step cloning and identification of MMR-deficient transformants since MMR-deficient cells exhibit red-white sectoring directly on transformation plates.
###end p 35
###begin title 36
Mutations identified
###end title 36
###begin p 37
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 974 975 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb1">1</xref>
###xml 987 988 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f2">2</xref>
###xml 1114 1118 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb2">2</xref>
###xml 1483 1487 1483 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1568 1572 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 13 18 <span type="species:ncbi:4932">yeast</span>
###xml 357 362 <span type="species:ncbi:4932">yeast</span>
###xml 871 876 <span type="species:ncbi:4932">yeast</span>
Hybrid human-yeast MLH1 expression plasmids were isolated from 387 transformants that exhibited a deficiency in MMR. DNA sequencing revealed that 60 of the transformants harbored hybrid MLH1 genes that were identical to the unmutagenized parental gene. In preliminary experiments, several of these molecules were tested functionally by re-introduction into yeast strain YBT24. The results of these quantitative MMR assays demonstrate that the encoded proteins complemented the repair defect as well as the original parental hybrid (data not shown). These findings indicate that the clones without an alteration in the mutagenized region were indeed false positives arising from the selection strategy and do not represent molecules with spontaneous mutations in other regions of the DNA. This number of false positives was not surprising considering the observation that yeast expressing the parental hybrid MLH1 genes exhibits a mutator phenotype at a low frequency (Table 1 and Figure 2). The remaining 327 sequenced genes exhibited at least one alteration in the mutagenized region. There were 24 (7.3%) hybrid MLH1 genes that contained a frameshift mutation and 16 (4.9%) that contained a termination codon (Table 2). The identification of these types of mutations validated the screening strategy because they would be expected to encode truncated MLH1 proteins that lack MMR function. There were 129 (39%) plasmids that contained multiple (2 or more) alterations in the hybrid MLH1 genes and these were not analyzed further. Finally, there were 158 (48%) hybrid MLH1 genes that contained a single missense codon; these represented the most abundant type of alteration found in the screen.
###end p 37
###begin p 38
###xml 221 223 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">16</sub>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f3">3</xref>
###xml 1028 1030 1028 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1232 1233 1232 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f3">3</xref>
###xml 1314 1316 1314 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1370 1374 1370 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1510 1512 1510 1512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1720 1721 1720 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f3">3</xref>
###xml 1802 1804 1802 1804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1984 1988 1984 1988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 832 837 <span type="species:ncbi:4932">yeast</span>
###xml 1049 1054 <span type="species:ncbi:4932">yeast</span>
###xml 1158 1163 <span type="species:ncbi:9606">human</span>
###xml 1196 1201 <span type="species:ncbi:4932">yeast</span>
###xml 1531 1536 <span type="species:ncbi:4932">yeast</span>
###xml 1633 1638 <span type="species:ncbi:9606">human</span>
###xml 1684 1689 <span type="species:ncbi:4932">yeast</span>
To verify the missense codons as mutations causing loss-of-MMR function, plasmids containing each variant gene were re-introduced into the parental strain (YBT24) for quantitative MMR assays based on stability of the (GT)16G microsatellite in pSH91. The mutation frequency of YBT24; pSH91 containing each cloned MLH1 variant was determined and compared to those levels exhibited by YBT24; pSH91 containing the appropriate parental hybrid gene or the empty expression vector pMETc. Importantly, we compared the mutation frequency of each variant to the mutation frequency of the corresponding parental hybrid to validate a loss-of-function because the two parental hybrids gave slightly different baseline values. Therefore, any effect on function is due to the amino acid substitution in the context of the appropriate hybrid human-yeast molecule. The results of two representative MMR assays, which tested missense variants in both pMLH1_h(41-86) and pMLH1_h(77-134), are shown in Figure 3. Mutation frequencies of 2.1-2.7 x 10-3 were exhibited by yeast cells carrying MLH1_h(41-86) genes encoding S44F, I47S, L56P, I59T, D63Y and I68N substitutions in the human and a V110A substitution in the yeast portion of the hybrid (Figure 3A). These mutation frequencies were similar to the mutation frequency of 2.3 x 10-3 conferred by the pMETc expression vector (lacking an MLH1 gene) and represent mutation defects of 7.2 or more compared to the parental hybrid MLH1_h(41-86). Mutation frequencies of 2.0-4.6 x 10-3 were exhibited by yeast cells carrying MLH1_h(77-134) genes encoding A103T, T114I, T115S and K118N substitutions in the human and L56H, N61S and G62E substitutions in the yeast portion of the hybrid (Figure 3B). These mutation frequencies were similar to the mutation frequency of 2.0 x 10-3 conferred by pMETc and represent mutation defects of 20 or more compared to the parental hybrid MLH1_h(77-134). The results demonstrate a substantial loss-of-MMR function for the MLH1 variants and further validate the screening procedure.
###end p 38
###begin p 39
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb3">3</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb4">4</xref>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb3">3</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb4">4</xref>
###xml 828 829 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb3">3</xref>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb4">4</xref>
###xml 1077 1078 1077 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb5">5</xref>
###xml 2068 2069 2068 2069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
###xml 1305 1310 <span type="species:ncbi:9606">human</span>
###xml 1318 1323 <span type="species:ncbi:4932">yeast</span>
###xml 1332 1337 <span type="species:ncbi:9606">human</span>
###xml 1345 1350 <span type="species:ncbi:4932">yeast</span>
###xml 1359 1364 <span type="species:ncbi:9606">human</span>
###xml 1372 1377 <span type="species:ncbi:4932">yeast</span>
###xml 1389 1394 <span type="species:ncbi:9606">human</span>
###xml 1402 1407 <span type="species:ncbi:4932">yeast</span>
###xml 1476 1481 <span type="species:ncbi:9606">human</span>
###xml 1486 1491 <span type="species:ncbi:4932">yeast</span>
###xml 1541 1546 <span type="species:ncbi:4932">yeast</span>
###xml 1555 1560 <span type="species:ncbi:9606">human</span>
###xml 1573 1578 <span type="species:ncbi:4932">yeast</span>
###xml 2122 2127 <span type="species:ncbi:9606">human</span>
###xml 2267 2272 <span type="species:ncbi:9606">human</span>
Each of the 158 MLH1 variants containing a missense codon was tested in quantitative MMR assays as described above. To confirm the loss-of-MMR function, we assigned a level of 2 or greater for the mutation defect. This level represents a mutation frequency twice as high as the parental MLH1_h(41-86) and MLH1_h(77-134) hybrids and exceeds the maximal levels typically observed for these hybrids (Tables 3 and 4, footnotes). The results of the quantitative MMR assays demonstrated that 151 of the isolated variants (representing 124 non-redundant alterations) exhibited a mutation defect of 2.1 or more. As listed in Tables 3 and 4 [for variants of MLH1_h(41-86) and MLH1_h(77-134), respectively], a range of MMR defects was apparent and the vast majority of missense codons conferred a substantial loss-of-MMR function (Tables 3 and 4; ++ and +++). In addition to amino acid substitutions that impaired MMR activity, seven amino acid substitutions conferred little-to-no loss-of-MMR function in quantitative assays and were classified as functionally inert alterations (Table 5). Variants containing these alterations probably arose as false positives in the prospective screen. A comparison of the amino acid substitutions which had a deleterious effect on MMR activity revealed four alterations [D41G (human)/D38G (yeast), T45I (human)/T42I (yeast), E53V (human)/E50V (yeast) and I68N (human)/I65N (yeast)] that predict identical amino acid substitutions in the equivalent human and yeast residues. Additionally, three alterations [I37T (yeast), F80L (human) and G144S (yeast)] were isolated in the same codon using different hybrids. Identification of equivalent mutations in different hybrids further supports the notion that these substitutions confer detrimental effects on MMR function. In total, 117 unique amino acid substitutions in the N-terminal end of MLH1p were shown to cause a loss-of-MMR function in this study. As compared to an alignment of MLH1p orthologs, the majority of these substitutions occur at highly conserved amino acid residues (Figure 4). Interestingly, 10 substitutions (corresponding to human MLH1p I19F, N38D, N38S, S44F, V49E, N64S, G67E, I68N, C77R and K84E) have been previously reported as possible pathogenic mutations in the human population.
###end p 39
###begin title 40
###xml 26 31 <span type="species:ncbi:9606">human</span>
Saturation mutagenesis at human MLH1 codons 43 and 44
###end title 40
###begin p 41
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c34">34</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c43">43</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c34">34</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c68">68</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c69">69</xref>
###xml 1510 1511 1508 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f5">5</xref>
###xml 1706 1708 1704 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1717 1719 1715 1717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1812 1813 1810 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f5">5</xref>
###xml 1923 1925 1921 1923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1934 1936 1932 1934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 603 608 <span type="species:ncbi:4932">yeast</span>
###xml 746 751 <span type="species:ncbi:9606">human</span>
To investigate the functional consequence of all possible amino acid substitutions at a specific residue, comprehensive mutagenesis was carried out on human MLH1 codons 43 and 44 in hybrid MLH1_h(41-86). The codons 43 and 44 were chosen because they lie in a region known to be functionally important (34,41,51,43), but variable amongst species (Figure 4). We also focused on these adjacent residues because S44F was one of the first human alterations identified as being strongly associated with the development of HNPCC (34). Moreover, the functional and biochemical effects of a comparable change in yeast (corresponding to A41S and A41F) has been widely studied (37,68,69) and these results could be used as a basis for comparison. In native human MLH1p, residue 43 is lysine (K43), a positively-charged hydrophilic residue, and residue 44 is serine (S44), an uncharged small polar residue. Mutagenized genes were introduced into YBT24 containing pSH91 and tested in the standardized quantitative MMR assay. Mutation frequencies were compared to those conferred by the parental hybrid MLH1_h(41-86) and the same strain carrying the empty expression vector (pMETc). As expected, a silent K43K (AAA-->AAG) alteration in MLH1_h(41-86) did not disrupt the MMR function compared to the parental hybrid MLH1_h(41-86), while spontaneous deletions in codons 43 ('frameshift-1') and 45 ('frameshift-2') exhibited mutation frequencies that were similar to that conferred by the empty expression vector pMETc (Figure 5). Of the 19 possible substitutions at codon 43, 14 (K43A, K43D, K43E, K43F, K43H, K43I, K43L, K43M, K43P, K43S, K43T, K43V, K43W and K43Y) conferred mutation frequencies in the range of 4.6 x 10-4-2.0 x 10-3. These values represent mutation defects of 2.0-8.5 compared to the parental hybrid (Figure 5). The remaining five alterations (K43C, K43G, K43N, K43Q and K43R) conferred mutation frequencies of 1.1 x 10-4-3.8 x 10-4, and values that represent a mutation defect of 1.6 or less thus have little-to-no effect on protein function.
###end p 41
###begin p 42
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f6">6</xref>
###xml 514 515 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f6">6</xref>
###xml 781 783 779 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 792 794 790 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 803 804 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f6">6</xref>
###xml 924 926 922 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 1378 1379 1376 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
Amino acid alterations at residue 44 showed that 18 of the 19 possible substitutions gave a pronounced loss-of-MMR function compared to the parental hybrid MLH1_h(41-86) (Figure 6). As expected, a silent S44S (TCC-->TCA) alteration in MLH1_h(41-86) did not disrupt the MMR function compared to the parental hybrid MLH1_h(41-86), while a hybrid containing a termination codon at position 44 ('S44-Term') exhibited a mutation frequency that was similar to that conferred by the empty expression vector pMETc (Figure 6). Eighteen (S44C, S44D, S44E, S44F, S44G, S44H, S44I, S44K, S44L, S44M, S44N, S44P, S44Q, S44R, S44T, S44V, S44W and S44Y) of the nineteen possible substitutions at codon 44 conferred a pronounced loss-of-MMR function with mutation frequencies in the range 5.8 x 10-4-3.4 x 10-3 (Figure 6), representing mutation defects of 2.2-12.6. The remaining alteration (S44A) conferred a mutation frequency of 5.8 x 10-5, which corresponds to a mutation defect of 0.2. While substitutions at residue S44 tended to be more severe (conferring a mutation defect of 5.0 or greater) than those at residue K43, the majority of substitutions at both codons impaired MMR activity to some degree. Interestingly, for both residues K43 and S44, the range of substitutions that resulted in little-to-no loss-of-MMR function closely mirrored the variability observed in nature (Figure 4).
###end p 42
###begin title 43
DISCUSSION
###end title 43
###begin p 44
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c70">70</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c71">71</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c74">74</xref>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c64">64</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c65">65</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c75">75</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c76">76</xref>
###xml 1327 1328 1327 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
###xml 47 52 <span type="species:ncbi:4932">yeast</span>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 192 197 <span type="species:ncbi:4932">yeast</span>
###xml 282 287 <span type="species:ncbi:9606">human</span>
###xml 366 372 <span type="species:ncbi:562">E.coli</span>
###xml 382 387 <span type="species:ncbi:4932">yeast</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 1237 1242 <span type="species:ncbi:9606">human</span>
In this study, a prospective genetic screen in yeast was developed to identify codon changes in MLH1 causing loss-of-MMR function. A key feature of this screen was the use of functional human-yeast hybrid genes (51), which allowed isolation of mutations in the ATPase domain of the human MLH1p. In earlier studies, prospective genetic screens have been performed in E.coli (70) and yeast (71-74) in order to investigate the structure and function of the native MMR proteins in those organisms. However, a prospective genetic screen for mutations specific to human MLH1 coding sequences has not been previously reported. In total, we have assembled functional information on 162 amino acid substitutions in the ATPase domain of MLH1p. The data consists of 117 replacements that impair MMR function, seven functionally silent alterations and the effects of all amino acid substitutions at residues K43 and S44 on protein function. Importantly, previously reported HNPCC-associated alterations [see MLH1 mutational databases and other reports (64,65,75,76)] exhibited considerable overlap with the loss-of-MMR function mutations reported here. Of 33 distinct HNPCC-associated substitutions which have been reported in the N-terminal end of human MLH1p, 10 identical alterations were isolated in our prospective screen (see Figure 4). The novel mutations identified in this study may aid in the interpretation of HNPCC genetic tests if the same variation is observed clinically.
###end p 44
###begin p 45
###xml 323 335 323 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c77">77</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c71">71</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c74">74</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c47">47</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c78">78</xref>
###xml 1248 1253 1248 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH2</italic>
###xml 1254 1258 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 1304 1309 1304 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hMSH2</italic>
###xml 1393 1395 1393 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c47">47</xref>
###xml 1396 1398 1396 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c78">78</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c79">79</xref>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 176 182 <span type="species:ncbi:9606">humans</span>
###xml 317 322 <span type="species:ncbi:4932">yeast</span>
###xml 323 335 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 581 586 <span type="species:ncbi:4932">yeast</span>
###xml 700 705 <span type="species:ncbi:4932">yeast</span>
###xml 720 725 <span type="species:ncbi:4932">yeast</span>
###xml 917 922 <span type="species:ncbi:4932">yeast</span>
###xml 979 984 <span type="species:ncbi:9606">human</span>
###xml 1001 1006 <span type="species:ncbi:4932">yeast</span>
###xml 1543 1548 <span type="species:ncbi:9606">human</span>
###xml 1549 1554 <span type="species:ncbi:4932">yeast</span>
###xml 1664 1669 <span type="species:ncbi:9606">human</span>
###xml 1691 1696 <span type="species:ncbi:4932">yeast</span>
This study describes a novel method for the identification of human MMR gene sequence alterations that impair function of the encoded protein in MMR. If such variants occur in humans, individuals harboring such alleles may have an elevated mutation rate and a predisposition to develop cancer. The method employs the yeast S.cerevisiae, which has been used previously for the identification of mutant MMR genes. For example, Jeyaprakash et al. (77) used genetic complementation experiments and then direct cloning and DNA sequencing to ascertain the identity of the mutant gene in yeast strains with preexisting defects in microsatellite stability. More recent reports describe global mutagenesis of yeast, selection of yeast strains for those having alterations in MMR gene activity followed by cloning and DNA sequencing (71-74). It should be noted that these studies were focused on finding variants of the native yeast proteins. Indeed, if reported at all, expression of the human MMR proteins in yeast has either no detectable biological activity (MSH2, MSH3 and MSH6) or induces a dominant negative mutator phenotype (MLH1 and the MSH2-MSH6 heterodimers) (47,78). Previous studies have attempted to bypass these impediments by using, e.g. an hMSH2-ADE2 fusion gene to screen for stop codons in the hMSH2 coding sequence or assays based on gain or loss of the dominant mutator phenotype (47,78,79). However, these assays do not measure the native biological activity of the protein. The approach described in this study, employing hybrid human-yeast MMR proteins that are functional in MMR (51), has allowed functional analyses of substitutions in the native human MMR gene sequence in yeast.
###end p 45
###begin p 46
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb3">3</xref>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb4">4</xref>
In this investigation, 27 codon alterations were isolated on two or more occasions (see Tables 3 and 4). Interestingly, only 4 of these 27 duplicates could have been due to cloning of the same amplified mutant from a single PCR fragment pool (data not shown). Instead, the majority of duplications were isolated in different gap repair screens using different PCR fragment pools and therefore represent independent generation of the same mutation. Thus, an important source of duplicity must be that (i) certain nucleotides are more prone to mutagenesis, i.e. 'mutational hotspots' (although two different polymerases and PCR amplification conditions were employed; see Materials and Methods) or (ii) the screen is reaching its limits in terms of the number of loss-of-function mutations possible. These possibilities are not mutually exclusive and the duplications may, in fact, result from a combination of these factors.
###end p 46
###begin p 47
###xml 480 487 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb2">2</xref>
###xml 1110 1117 1110 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1126 1127 1126 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f5">5</xref>
###xml 1382 1383 1382 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f6">6</xref>
###xml 1480 1481 1480 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb3">3</xref>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
###xml 350 355 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:4932">yeast</span>
###xml 897 902 <span type="species:ncbi:9606">human</span>
###xml 1493 1498 <span type="species:ncbi:9606">human</span>
The results of this investigation raise an important question. How many loss-of-MMR function mutations might be expected in the human MLH1 region that was mutagenized? To estimate this number, we compared the experimental results to all possible single nucleotide missense codons at human codons 41-86 and 77-134. This analysis was restricted to the human portion of each hybrid since the crossover site sites between yeast sequences in the vector and mutagenized fragment during in vivo gap repair will vary slightly between clones. The first estimate was based on the number of possible termination codons actually isolated in the prospective screen (Table 2). For hybrids MLH1_h(41-86) and MLH1-h(77-134), 5 of 16 (31%) and 5 of 21 (23%) of possible stop codons, respectively, were isolated. A second estimate is based on the results obtained by making all possible amino acid substitutions at human residues K43 and S44. At position 43, six different single base substitution codon changes (K43E, K43I, K43N, K43Q, K43R and K43T) are possible. Three of these exhibit 2-fold or greater loss-of-MMR function in vivo (Figure 5; K43E, K43I and K43T). Only a K43I codon was isolated in the prospective screen. At position 44, six different single base substitution codon changes (S44A, S44C, S44F, S44P, S44T and S44Y) are possible. Five of these confer loss-of-MMR function (Figure 6; S44C, S44F, S44P, S44T and S44Y), and one (S44F) was isolated in the prospective screen (Table 3). Thus, at human codons K43 and S44, 33% (1 of 3) and 20% (1 of 5), respectively, of all single base substitution mutations were isolated. Cumulatively, this analysis suggests that we have identified approximately25% of all single base substitution missense mutations in this region, implying that the total number of MLH1-inactivating amino acid substitutions in the region of MLH1 subjected to mutagenesis is approximately460.
###end p 47
###begin p 48
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh855tb5">5</xref>
###xml 1389 1393 1389 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
The majority of amino acid substitutions that conferred a loss-of-MMR function were isolated at highly-conserved residues (Figure 4). Only 3 of the 117 substitutions that conferred loss-of-MMR function (hMLH1 K52E, K118I and P139H) occurred as the native amino acid at the equivalent position in any MLH1p from nine other species. In contrast, five of seven substitutions that exhibited little-to-no loss-of-MMR function (Table 5) occurred naturally at the equivalent position in other species. There were several amino acid substitutions whose functional consequence may not have been predicted based on either the variation in nature or the biochemical properties of the alternate residues. For example, we found the biochemically conservative alterations hMLH1p D38E (both acidic), S46T (both uncharged polar) and N64S (both uncharged polar) resulted in loss-of-MMR function. Some alterations that may have been expected to confer detrimental effects on MMR function gave little-to-no loss of function. Thus, the substitutions I72T, K43C and K43G, which considerably alter the charge, polarity and size of the residue, did not substantially impair MMR function. Clearly, the functional consequence of any substitution requires direct experimental evaluation. This point is particularly relevant for the interpretation of HNPCC genetic tests, which often reveal novel missense codons in MLH1 and other MMR genes.
###end p 48
###begin p 49
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
###xml 192 198 192 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c40">40</xref>
###xml 535 537 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c38">38</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c39">39</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 702 704 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c38">38</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c39">39</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 1299 1301 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 1446 1447 1446 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f1">1</xref>
###xml 1477 1481 1477 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1599 1603 1599 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 1691 1695 1691 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 192 198 <span type="species:ncbi:562">E.coli</span>
###xml 242 247 <span type="species:ncbi:4932">yeast</span>
###xml 252 257 <span type="species:ncbi:9606">human</span>
###xml 1672 1677 <span type="species:ncbi:9606">human</span>
###xml 1678 1683 <span type="species:ncbi:4932">yeast</span>
As summarized in Figure 4, amino acid substitutions causing loss-of-MMR function were identified at 61 residues throughout the N-terminal ATPase domain of MLH1p. Previous structural models of E.coli MutL (41,42) and biochemical studies using yeast and human MLH1p (37-40) provide a foundation for understanding as to why substitutions at certain residues may impair MMR function. Three substitutions causing loss-of-MMR function were identified at the residue corresponding to hMLH1p N38, which helps to position a centrally located Mg2+ ion presumed to be important for ATP binding (38,39,42). The amino acid substitutions identified (corresponding to hMLH1p N38D, N38S and N38T) may either abolish Mg2+ interactions or alter the placement of this critical ion. Substitutions were also identified at residues corresponding to hMLH1p D63, T82, S83, F99 and R100, which appear to have a direct role in ATP binding (38,39,42). These substitutions are likely to perturb ATP binding and/or hydrolysis and, thus, prevent the conformational changes in MLH1p which are predicted to signal downstream MMR events. Most of the substitutions causing loss-of-MMR function were localized in the region corresponding to hMLH1p 41 through 86, which make up a large portion of the ATP-binding pocket and 'ATP lid' (41,42). Although this region is certainly important for DNA MMR, we suspect that many mutations were localized here because, as depicted in Figure 1B, this portion of the mutant MLH1 gene originates solely from recombination with a mutagenized PCR fragment. A mutational analysis of other regions of MLH1 will require different gapped vector DNAs and the use of additional human-yeast hybrid MLH1 genes.
###end p 49
###begin p 50
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 172 174 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 175 177 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 369 371 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 372 374 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c38">38</xref>
###xml 375 377 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c42">42</xref>
###xml 739 741 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c34">34</xref>
###xml 742 744 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c68">68</xref>
###xml 745 747 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c69">69</xref>
###xml 782 789 774 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 791 793 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 794 796 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c43">43</xref>
###xml 1805 1807 1797 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 34 40 <span type="species:ncbi:562">E.coli</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:4932">yeast</span>
###xml 696 701 <span type="species:ncbi:9606">human</span>
###xml 720 725 <span type="species:ncbi:9606">human</span>
###xml 835 840 <span type="species:ncbi:9606">human</span>
###xml 841 846 <span type="species:ncbi:4932">yeast</span>
###xml 1634 1639 <span type="species:ncbi:9606">human</span>
Based on the crystal structure of E.coli MutL, human MLH1p residues K43 and S44 are expected to lie adjacent to helix alphaA within a conserved ATP-binding motif (motif I)(41,42). It has been predicted that mutations in and around helix Aalpha dislocate a conserved glutamic acid residue, corresponding to hMLH1p E34, which is important for ATP binding and hydrolysis (37,38,42). Specific biochemical functions have not been assigned to K43 or S44, but as shown in this investigation alterations in the size, charge and polarity of these residues result in distinct functional consequences for MLH1p. Previous investigations using the native yeast MLH1p have shown that substitutions mimicking a human HNPCC alteration (human MLH1p S44F) (34,68,69) result in a loss-of-MMR function in vivo (51,43). We confirmed this finding using the human-yeast hybrid gene MLH1_h(41-86) and showed that all amino acid substitutions except S44A impaired MMR function. At position 44, it appears that the small, uncharged side chains on serine and alanine are critical for proper MLH1p structure and/or function. At position K43, the systematic substitution of all possible amino acids resulted in a variety of functional consequences. In general, the introduction of amino acids with bulky and/or hydrophobic side chains tended to result in loss-of-MMR activity, while the introduction of amino acids with hydrophilic side chains were functionally tolerated. In addition, the results of this systematic analysis of all possible amino acid substitutions is consistent with our previous investigations, in which it was shown that substitutions in the human population can be either silent polymorphisms, inactivating mutations, or give rise to proteins that reduce the efficiency of MMR relative to the parental molecule (51).
###end p 50
###begin p 51
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c25">25</xref>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c26">26</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c31">31</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c32">32</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c80">80</xref>
###xml 1510 1512 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c17">17</xref>
###xml 1513 1515 1513 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 1516 1518 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 1519 1521 1519 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c44">44</xref>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:4932">yeast</span>
###xml 228 233 <span type="species:ncbi:4932">yeast</span>
###xml 292 297 <span type="species:ncbi:4932">yeast</span>
###xml 364 369 <span type="species:ncbi:9606">human</span>
The goal of this investigation is to identify MLH1p amino acid substitutions which impair DNA MMR in vivo. As noted, both human-yeast hybrid MLH1 proteins are functional in MMR but at a reduced efficiency compared to the native yeast protein. This is presumably due to the replacement of the yeast coding sequence with the conserved, but not identical, homologous human coding sequence. There is a formal possibility, therefore, that some of the missense codons we identified are specific to the hybrid protein and might not be observed when introduced to a native protein. Extrapolation of the results of this study to native proteins should consider the caveat that a subset of the variants may be specific to the hybrid molecule. At this time, it is not possible to conclude whether the missense mutations identified perturb other functions of MLH1p, such as its role in meiotic crossing-over (25,26), and signaling of apoptosis in response to DNA damage (31,32). However, based on the results of a recent investigation (80), it appears that the majority of the mutations the ATPase domain that inactivate MMR also inactivate meiotic crossing-over. Further studies will be required to determine whether the ATPase activity of MLH1p is critical in other functions of the protein. Further studies will also be required to determine whether the substitutions have detrimental effects on the stability and/or solubility of MLH1p, protein-protein interactions and/or specific steps in ATP binding or hydrolysis (17,37,41,44).
###end p 51
###begin p 52
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 393 398 <span type="species:ncbi:9606">human</span>
Understanding the functional consequence of missense codons in MLH1 is critical for increasing the utility of genetic tests for HNPCC. As described in this investigation, a rapid and biologically relevant strategy may be to accumulate functional information concerning putative disease-causing mutations in a prospective manner. Extending the prospective screen through additional portions of human MLH1 and other MMR genes could result in a comprehensive catalog of missense mutations that cause loss-of-MMR function.
###end p 52
###begin title 53
Figures and Tables
###end title 53
###begin p 54
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 35 50 35 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 91 93 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">19</sub>
###xml 97 99 97 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18</sub>
###xml 125 128 125 128 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ATG</underline>
###xml 167 170 167 170 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GAT</underline>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 201 216 201 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlh1</italic>
###xml 305 309 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
###xml 344 345 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 416 420 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 543 546 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 548 551 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aat</italic>
###xml 692 699 688 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 848 852 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlh1</italic>
###xml 948 952 944 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlh1</italic>
###xml 990 996 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 252 257 <span type="species:ncbi:4932">yeast</span>
###xml 435 440 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:4932">yeast</span>
###xml 771 776 <span type="species:ncbi:4932">Yeast</span>
###xml 990 996 <span type="species:ncbi:562">E.coli</span>
 (A) Sequence of the 5' end of the ADE2::MS3::ADE2 reporter allele. The microsatellite (AC)19A(G)18 was inserted between the ATG initiator codon and the second codon (GAT) of the native ADE2 gene. The ADE2::MS3::ADE2 allele was introduced into haploid yeast strain YBT24 (mlh1Delta), replacing the native ADE2 allele to generate strain YBT41. (B) Schematic representation of the screen for inactivating mutations in MLH1. Fragments of human-yeast hybrid genes pMLH1_h(41-86) and pMLH1_h(77-134) were generated by error-prone PCR, mixed with a ClaI-AatII-digested pMLH1 expression vector and transformed into strains YBT24 (Method 'a') or YBT41 (Method 'b'). Circularized plasmids were formed in vivo by homologous recombination between the PCR product and gapped vector. Yeast transformants with a MMR-deficient phenotype (i.e. containing a mutant mlh1 gene) are identified phenotypically as described in the figure. Plasmids containing the mutant mlh1 gene are recovered by shuttling into E.coli and sequenced to determine the nucleotide alteration(s) present in the mutagenized gene.
###end p 54
###begin p 55
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 249 253 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 396 411 395 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 437 441 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade2</italic>
###xml 658 673 657 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
 Appearance of YBT41 colonies following transformation with different MLH1 expression vectors. YBT41 colonies were grown on plates containing low adenine (4 mug/ml) after the introduction of plasmids pMETc, the parental expression vector without an MLH1 gene, pMLH1, pMLH1_h(41-86) and pMLH1_h(77-134) (as indicated). Colonies with red-white sectoring indicate a high level of instability in the ADE2::MS3::ADE2 allele, i.e. mutation to ade2 (mutant cells appear red due to the accumulation of an intermediate in adenine biosynthesis). In all transformations, a background of 10% red colonies was consistently observed and may be a result of mutation in the ADE2::MS3::ADE2 allele prior to, or shortly after, transformation.
###end p 55
###begin p 56
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 519 520 517 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 620 622 618 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 646 648 644 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 672 674 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 698 700 696 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 724 726 722 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 750 752 748 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 777 779 775 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 805 807 803 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 824 826 822 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 829 830 827 828 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 932 934 930 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 958 960 956 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 984 986 982 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1011 1013 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1038 1040 1036 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1065 1067 1063 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1092 1094 1090 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1121 1123 1119 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1140 1142 1138 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1 6 <span type="species:ncbi:4932">Yeast</span>
###xml 604 609 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 656 661 <span type="species:ncbi:9606">human</span>
###xml 682 687 <span type="species:ncbi:9606">human</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
###xml 761 766 <span type="species:ncbi:4932">yeast</span>
###xml 916 921 <span type="species:ncbi:4932">yeast</span>
###xml 942 947 <span type="species:ncbi:4932">yeast</span>
###xml 968 973 <span type="species:ncbi:4932">yeast</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1022 1027 <span type="species:ncbi:9606">human</span>
###xml 1049 1054 <span type="species:ncbi:9606">human</span>
###xml 1076 1081 <span type="species:ncbi:9606">human</span>
 Yeast strain YBT24 containing pSH91 was transformed with pMLH1_h(41-86), pMLH1_h(77-134), variants of these plasmids isolated in the prospective screen and the expression vector pMETc lacking an MLH1 gene. Mutation frequencies were determined using the standardized quantitative MMR assay as described in Materials and Methods. The mean mutation frequency +/- SD of two independent cultures is shown. The species (noted in parenthesis) indicate the portion of the hybrid protein containing the amino acid alteration. (A) Mutation frequencies of pMLH_h(41-86) variants and controls: pMLH1_h(41-86) S44F (human), 2.7 x 10-3; I47S (human), 2.3 x 10-3; L56P (human), 2.7 x 10-3; I59T (human), 2.1 x 10-3; D63Y (human), 2.3 x 10-3; I68N (human), 2.5 x 10-3; V110A (yeast), 2.4 x 10-3; pMLH1_h(41-86), 2.9 x 10-4; pMETc, 2.3 x 10-3. (B) Mutation frequencies of pMLH_h(77-134) variants and controls: pMLH1_h(77-134) L56H (yeast), 2.5 x 10-3; N61S (yeast), 3.2 x 10-3; G62E (yeast), 3.6 x 10-3; A103T (human), 2.0 x 10-3; T114I (human), 2.0 x 10-3; T115S (human), 3.4 x 10-3; K118N (human), 4.6 x 10-3; pMLH1_h(77-134), 1.4 x 10-4; pMETc, 2.0 x 10-3.
###end p 56
###begin p 57
###xml 205 214 205 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H.sapiens</italic>
###xml 228 238 228 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M.musculus</italic>
###xml 250 262 250 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R.norvegicus</italic>
###xml 280 294 280 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D.melanogaster</italic>
###xml 308 320 308 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 350 360 350 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A.thaliana</italic>
###xml 377 386 377 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C.elegans</italic>
###xml 406 414 406 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.aureus</italic>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 595 601 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 620 622 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 761 763 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c37">37</xref>
###xml 764 766 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c41">41</xref>
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 205 214 <span type="species:ncbi:9606">H.sapiens</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 228 238 <span type="species:ncbi:10090">M.musculus</span>
###xml 241 244 <span type="species:ncbi:10116">rat</span>
###xml 250 262 <span type="species:ncbi:10116">R.norvegicus</span>
###xml 265 274 <span type="species:ncbi:7227">fruit fly</span>
###xml 280 294 <span type="species:ncbi:7227">D.melanogaster</span>
###xml 297 302 <span type="species:ncbi:4932">yeast</span>
###xml 308 320 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 329 336 <span type="species:ncbi:4896">S.pombe</span>
###xml 350 360 <span type="species:ncbi:3702">A.thaliana</span>
###xml 377 386 <span type="species:ncbi:6239">C.elegans</span>
###xml 406 414 <span type="species:ncbi:1280">S.aureus</span>
###xml 423 429 <span type="species:ncbi:562">E.coli</span>
###xml 595 601 <span type="species:ncbi:562">E.coli</span>
###xml 999 1004 <span type="species:ncbi:9606">human</span>
 Amino acid alignment of MLH1p orthologs. The 117 amino acid substitutions causing loss-of-MMR function are noted above the appropriate residue in the human MLH1p sequence. MLH1p sequences from human (Hs, H.sapiens), mouse (Mm, M.musculus), rat (Rn, R.norvegicus), fruit fly (Dm, D.melanogaster), yeast (Sc, S.cerevisiae and Sp, S.pombe), plant (At, A.thaliana), flatworm (Ce, C.elegans) and bacteria (Sa, S.aureus and Ec, E.coli) were aligned using ClustalW (). Conserved residues are highlighted. Structural features, including alpha-helices (stippled boxes) and beta-strands (arrows), in the E.coli MutL polypeptide (41) are indicated below the alignment. Barbells represent the location of the ATP binding motifs (I-IV), which are conserved in GHL ATPases (37,41). Underlined residues have been previously reported, as a result of HNPCC genetic testing, to exhibit missense alterations. Boxed residues (substitutions) were isolated in this study and are equivalent to substitutions found in the human population and associated with HNPCC (see Materials and Methods).
###end p 57
###begin p 58
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 591 593 589 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:4932">Yeast</span>
 Mutation frequencies conferred by missense substitutions at human MLH1 codon 43 (K43). Yeast strain YBT24 containing pSH91 was transformed with pMLH1_h(41-86), variants of this plasmid containing the indicated amino acid substitution, and the expression vector pMETc lacking an MLH1 gene. Mutation frequencies were determined using the standardized quantitative MMR assay as described in Materials and Methods. The mean mutation frequency +/- SD of two to nine independent cultures is shown. The cells containing the parental hybrid pMLH1_h(41-86) exhibited a mutation frequency of 2.3 x 10-4. The mutation defect (shown above each bar) for each variant and control was calculated by dividing the mutation frequency of cells expressing the variant by the mutation frequency of cells expressing parental hybrid pMLH1_h(41-86). MLH1_h(41-86) genes containing spontaneous nucleotide deletions in codon 43 (an A-deletion) and 45 (a CA-deletion) are referred to as 'frameshift-1' and '-2', respectively.
###end p 58
###begin p 59
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 593 595 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:4932">Yeast</span>
 Mutation frequencies conferred by missense substitutions at human MLH1 codon 44 (S44). Yeast strain YBT24 containing pSH91 was transformed with pMLH1_h(41-86), variants of this plasmid containing the indicated amino acid substitution, and the expression vector pMETc lacking an MLH1 gene. Mutation frequencies were determined using the standardized quantitative MMR assay as described in Materials and Methods. The mean mutation frequency +/- SD of two to twelve independent cultures is shown. The cells containing the parental hybrid pMLH1_h(41-86) exhibited a mutation frequency of 2.7 x 10-4. The mutation defect (shown above each bar) for each variant and control was calculated by dividing the mutation frequency of cells expressing the variant by the mutation frequency of cells expressing parental hybrid pMLH1_h(41-86). A MLH1_h(41-86) gene containing a termination codon at position 44 is referred to as 'S44-Term'.
###end p 59
###begin title 60
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 29 34 <span type="species:ncbi:4932">yeast</span>
Functional analysis of human-yeast hybrid MLH1 genes
###end title 60
###begin p 61
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 61 76 61 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2::MS3::ADE2</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 563 564 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f2">2</xref>
###xml 686 690 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE2</italic>
aYeast strain YBT41, which contains an MLH1 deletion and the ADE2::MS3::ADE2 allele, was transformed with expression vectors carrying the indicated MLH1 gene or the parental expression vector pMETc lacking an MLH1 gene ('None') and cells were plated on SD medium lacking histidine and containing 4 mug/ml adenine. Colonies (CFU), which are transformants since they grow without added histidine, were counted and visually inspected for red-white sectoring. In all transformations a background of approximately10% red colonies was consistently observed (see Figure 2) and these colonies were excluded from our analysis. The origin of these colonies are presumably host cells in which the ADE2 gene had mutated prior to, or shortly after, the transformation. Percentages were based on counts of 200-1200 colonies.
###end p 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
bMutation frequencies were based on forward mutation to canavanine resistance and were determined for the MLH1-deletion strain YBT24 harboring the indicated MLH1 gene or the parental expression vector pMETc ('None'). The median value of nine independent cultures is shown. Mutation defects were calculated with respect to the mutation frequency conferred by the wild-type MLH1 gene.
###end p 62
###begin p 63
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 93 95 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">16</sub>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
cMutation frequencies were determined using a URA3 reporter gene preceded by an in-frame (GT)16G microsatellite. Values are from (51).
###end p 63
###begin title 64
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLH1</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
Termination codons identified in hybrid human-yeast MLH1 genes
###end title 64
###begin p 65
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f1">1</xref>
###xml 36 41 <span type="species:ncbi:4932">yeast</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
aCodon numbering is relative to the yeast or human portion of the hybrid MLH1 proteins (see Figure 1B).
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
bProspective screening methods utilized yeast strain YBT24 for semi-quantitative patch assays (Method 'a') or YBT41 for the colorimetric assay (Method 'b') as described in the Materials and Methods.
###end p 66
###begin title 67
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 44 49 <span type="species:ncbi:4932">yeast</span>
MLH1 missense mutations identified in human-yeast hybrid MLH1_h(41-86)
###end title 67
###begin p 68
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aMMR-deficient transformants were identified by ('a') qualitative patch assays using YBT24 or ('b') colorimetric assay using YBT41 as described in the Materials and Methods section.
###end p 68
###begin p 69
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 755 757 755 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 778 780 778 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 869 871 869 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 892 894 892 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
bYeast strain YBT24 containing pSH91 was transformed with pMLH1_h(41-86) containing the indicated missense mutations. Mutation frequencies were determined using a standardized MMR assay based on instability of the GT-tract in pSH91 [Ellison et al., (51)]. To calculate the mutation defect, the mean mutation frequency conferred by each variant was divided by the mutation frequency conferred by the parental MLH1_h(41-86) gene. +, Mutation defect of 2.1 to 3.9 (18-33% loss-of-MMR function relative to the mutation frequency of the MLH1-null strain YBT24); ++, Mutation defect of 4.0-7.6 (34-66% loss-of-MMR function); +++, Mutation defect of 7.8 or greater (>67% loss-of-MMR function). The mean mutation frequency conferred by pMLH1_h(41-86) was 2.7 x 10-4 (range: 1.1-4.4 x 10-4) The mean mutation frequency conferred by the empty expression vector pMETc was 3.2 x 10-3 (range: 1.9-7.0 x 10-3) (mutation defect = 11.7).
###end p 69
###begin p 70
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cIn addition to the indicated missense mutation, the following silent alterations were observed (mutation/silent alteration): A42V/F85F; K57E/T45T; I68S/I47I and I75I; R79W/D143D; F80S/L73L; E86G/T82T and K142K; V110A/T66T.
###end p 70
###begin title 71
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 44 49 <span type="species:ncbi:4932">yeast</span>
MLH1 missense mutations identified in human-yeast hybrid MLH1_h(77-134)
###end title 71
###begin p 72
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aMMR-deficient transformants were identified by (Method 'a') qualitative patch assays using YBT24 or (Method 'b') colorimetric assay using YBT41 as described in the Materials and Methods.
###end p 72
###begin p 73
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh855c51">51</xref>
###xml 756 758 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 779 781 779 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 871 873 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 894 896 894 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
bYeast strain YBT24 containing pSH91 was transformed with pMLH1_h(77-134) containing the indicated missense mutations. Mutation frequencies were determined using a standardized MMR assay based on instability of the GT-tract in pSH91 [Ellison et al., (51)]. To calculate the mutation defect, the mean mutation frequency conferred by each variant was divided by the mutation frequency conferred by the parental MLH1_h(77-134) gene. +, Mutation defect of 2.5-9.0 (9-33% loss-of-MMR function relative to the mutation frequency of the MLH1-null strain YBT24); ++, Mutation defect of 9.1-17.9 (34-66% loss-of-MMR function); +++, Mutation defect of 18.0 or greater (>67% loss-of-MMR function). The mean mutation frequency conferred by pMLH1_h(77-134) was 1.2 x 10-4 (range: 0.6-2.4 x 10-4). The mean mutation frequency conferred by the empty expression vector pMETc was 3.3 x 10-3 (range: 1.8-7.0 x 10-3) (mutation defect = 27.5).
###end p 73
###begin p 74
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cIn addition to the indicated missense mutation the following silent alterations were observed (mutation/silent alteration): N40I/K134K; F80L/A92A; G101D/K54K; I115S/T116T.
###end p 74
###begin p 75
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
dThe missense mutation TTC-->TTA was also identified.
###end p 75
###begin title 76
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
MLH1p amino acid substitutions conferring minimal loss-of-MMR functiona
###end title 76
###begin p 77
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 211 213 211 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 243 245 243 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 309 311 309 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 342 344 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 379 381 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
aMutation frequencies were measured using the standardized GT-tract instability assay as described in Materials and Methods. Mutation frequencies were MLH1_h(41-86) Q62R, 3.6 x 10-4; MLH1_h(41-86) N64D, 2.1 x 10-4; MLH1_h(41-86) E71D, 3.2 x 10-4; MLH1_h(77-134) M33L, 4.0 x 10-5; MLH1_h(77-134) I72T, 1.0 x 10-4; MLH1_h(77-134) S95T, 4.6 x 10-5 and MLH1_h(77-134) L133S, 1.5 x 10-4. These values represent mutation defects of 1.4, 0.8, 1.2, 0.3, 0.9, 0.4 and 1.3, respectively, compared to the appropriate parental hybrid gene.
###end p 77
###begin p 78
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 15 20 <span type="species:ncbi:4932">yeast</span>
bMMR-deficient yeast colonies were identified by qualitative patch assays using YBT24 (Method 'a') or colorimetric assay using YBT41 (Method 'b') as described in Materials and Methods.
###end p 78
###begin p 79
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh855f4">4</xref>
cIndicates whether the variant (new) residue is present at the corresponding position in other species (Figure 4).
###end p 79
###begin title 80
ACKNOWLEDGEMENTS
###end title 80
###begin p 81
We thank Samantha Bohanon for technical assistance in the early stages of this project. This work was supported by a grant from the National Institutes of Health to G.A.B. (R44 CA081965).
###end p 81
###begin title 82
REFERENCES
###end title 82

